Menu

Market-Moving News for March 4th

Benzinga Newsdesk 1 year ago

MoversTrading Ideas

CAPR: 20% | Capricor Therapeutics shares are trading higher after the FDA accepted and granted priority review for the company's Biologics License Application for Deramiocel to treat Duchenne Muscular

Read the original